Lista de obras -

A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors

artículo científico publicado en 2017

Adoptive cell therapy against EBV-related malignancies: a survey of clinical results

scientific article published on 01 September 2008

Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer.

artículo científico publicado en 2011

Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4.

scientific article published on January 2009

Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer

artículo científico publicado en 2015

Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders

artículo científico publicado en 2012

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells

artículo científico publicado en 2017

Functional avidity-driven activation-induced cell death shapes CTL immunodominance

artículo científico publicado en 2014

IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas.

artículo científico publicado en 2012

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas

artículo científico publicado en 2013

Immunotherapy for EBV-associated malignancies.

artículo científico publicado en 2011

Impact of γ-chain cytokines on EBV-specific T cell cultures.

artículo científico publicado en 2010

In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growt

artículo científico publicado en 2014

PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models

artículo científico publicado en 2014

Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs

artículo científico publicado en 2014

Reverse immunoediting: When immunity is edited by antigen

artículo científico publicado en 2016

Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer

artículo científico publicado en 2010

Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.

artículo científico publicado en 2017

Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).

artículo científico publicado en 2013

The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders

artículo científico publicado en 2010

Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors

artículo científico publicado en 2010

Lista de obras de

A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors

Adoptive cell therapy against EBV-related malignancies: a survey of clinical results

Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer.

Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4.

Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer

Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells

Functional avidity-driven activation-induced cell death shapes CTL immunodominance

IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas.

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas

Immunotherapy for EBV-associated malignancies.

Impact of γ-chain cytokines on EBV-specific T cell cultures.

In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growt

PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models

Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs

Reverse immunoediting: When immunity is edited by antigen

Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer

Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.

Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).

The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders

Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors